Periventricular white matter flumazenil binding and postoperative outcome in hippocampal sclerosis

Epilepsia

Volumn 46, Issue 6, 2005, Pages 944-948

  Hammers, Alexander ^a,b   Koepp, Matthias J ^a,b   Brooks, David J ^a   Duncan, John S ^b,c  

^a HAMMERSMITH HOSPITAL   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c NATIONAL HOSPITAL FOR NEUROLOGY AND NEUROSURGERY   (United Kingdom)

Author keywords

Epilepsy; PET; SPM99; Statistical parametric mapping; Temporal lobe epilepsy

Indexed keywords

CARBON 11; FLUMAZENIL; FLUMAZENIL C 11; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BRAIN SIZE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG DISTRIBUTION; FEMALE; HIPPOCAMPAL SCLEROSIS; HUMAN; MALE; PERIKARYON; PRIORITY JOURNAL; TEMPORAL LOBECTOMY; WHITE MATTER;

ADULT; BRAIN; CEREBRAL VENTRICLES; EPILEPSY, TEMPORAL LOBE; FEMALE; FLUMAZENIL; HIPPOCAMPUS; HUMANS; MALE; SCLEROSIS;

EID: 20544453763     PISSN: 00139580     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1528-1167.2005.30904.x     Document Type: Article

References (18)

1. Abosch A, Bernasconi N, Boling W, et al. Factors predictive of suboptimal seizure control following selective amygdalohippocampectomy. J Neurosurg 2002;97:1142-51.
2. Raymond AA, Fish DR, Stevens JM, et al. Association of hippocampal sclerosis with cortical dysgenesis in patients with epilepsy. Neurology 1994;44:1841-5.
3. Li LM, Dubeau F, Andermann F, et al. Periventricular nodular heterotopia and intractable temporal lobe epilepsy: poor outcome after temporal lobe resection. Ann Neurol 1997;41:662-8.
4. Sisodiya SM, Moran N, Free SL, et al. Correlation of widespread preoperative magnetic resonance imaging changes with unsuccessful surgery for hippocampal sclerosis. Ann Neurol 1997;41:490-6.
5. Raymond AA, Fish DR, Sisodiya SM, et al. Abnormalities of gyration, heterotopias, tuberous sclerosis, focal cortical dysplasia, microdysgenesis, dysembryoplastic neuroepithelial tumour and dysgenesis of the archicortex in epilepsy: clinical, EEG and neuroimaging features in 100 adult patients. Brain 1995;118(Pt 3):629-60.
6. 11C]-flumazenil PET in mesial temporal lobe epilepsy. Neurology 2001;56:897-906.
7. 11C]flumazenil binding in temporal lobe epilepsy with normal MRI. Brain 2002;125:2257-71.
8. Hammers A, Koepp MJ, Richardson MP, et al. Grey and white matter flumazenil binding in neocortical epilepsy with normal MRI: a PET study of 44 patients. Brain 2003;126:1300-18.
9. Engel J Jr. Outcome with respect to seizures. In: Engel J Jr, ed. Surgical treatment of the epilepsies. New York: Raven Press, 1987:553-72.
10. Koepp MJ, Richardson MP, Brooks DJ, et al. Cerebral benzodiazepine receptors in hippocampal sclerosis: an objective in vivo analysis. Brain 1996;119(Pt 5):1677-87.
11. Hammers A, Koepp MJ, Free SL, et al. Implementation and application of a brain template for multiple volumes of interest. Hum Brain Mapp 2002;15:165-74.
12. Cunningham VJ, Jones T. Spectral analysis of dynamic PET data. J Cereb Blood Flow Metab 1993;13:15-23.
13. Ashburner J, Friston KJ. Nonlinear spatial normalization using basis functions. Hum Brain Mapp 1999;7:254-66.
14. Friston KJ, Holmes AP, Worsley KJ, et al. Statistical parametric maps in functional imaging: a general linear approach. Hum Brain Mapp 1995;2:189-210.
15. 11C-flumazenil PET in patients with refractory temporal lobe epilepsy and normal MRI. Neurology 2000;54:332-9.
16. Hannan AJ, Servotte S, Katsnelson A, et al. Characterization of nodular neuronal heterotopia in children. Brain 1999;122:219-38.
17. Richardson MP, Koepp MJ, Brooks DJ, et al. Cerebral activation in malformations of cortical development. Brain 1998;121:1295-304.
18. Isnard J, Guenot M, Sindou M, et al. Clinical manifestations of insular lobe seizures: a stereo-electroencephalographic study. Epilepsia 2004;45:1079-90.